JC

James Calloway

Financial Reporter

James Calloway is a financial reporter at StockTi covering corporate earnings, regulatory policy, and market-moving events. A former business journalist with Reuters, James has covered financial markets for over eight years across New York and Washington. He specializes in breaking down earnings reports, SEC filings, and policy decisions that affect publicly traded companies and investor portfolios.

Earnings, Regulation 903 articles

Articles by James Calloway

Vistry Plunges on Margin Outlook, Leadership Transition
Earnings

Vistry Plunges on Margin Outlook, Leadership Transition

Vistry Group stock tumbled more than 20% as the UK homebuilder warned of compressed margins for 2026 and revealed its executive chair will step down, with debt reduction taking priority over shareholder returns.

EWU
Wix Secures $250M Investment, Posts Mixed Q4 Results, and Unveils 2026 Outlook
Earnings

Wix Secures $250M Investment, Posts Mixed Q4 Results, and Unveils 2026 Outlook

Wix has entered into a $250 million private placement agreement and reported fourth-quarter revenue of $524.3 million, a 14% increase. The company also issued a 2026 outlook projecting mid-teens growth.

WIX
Adidas Shares Slide on 2026 Profit Guidance Miss, CEO Contract Extended
Earnings

Adidas Shares Slide on 2026 Profit Guidance Miss, CEO Contract Extended

Adidas AG shares dropped sharply after the company projected 2026 operating profit of approximately €2.3 billion, missing analyst expectations. The sportswear giant pointed to U.S. import tariffs and a weaker dollar as primary challenges.

NKE
CrowdStrike Posts Strong Q4, Guides Higher Amid AI Security Focus
Earnings

CrowdStrike Posts Strong Q4, Guides Higher Amid AI Security Focus

CrowdStrike Holdings reported fourth-quarter results that exceeded profit expectations and raised its annual recurring revenue target. The cybersecurity firm also issued forward-looking revenue guidance for fiscal 2027 and disclosed new share repurchases.

CRWD PANW FTNT MSFT
Lilly Shares Decline Ahead of Key FDA Obesity Pill Decision
Regulation

Lilly Shares Decline Ahead of Key FDA Obesity Pill Decision

Eli Lilly shares declined for a second day as the market anticipates an FDA decision on its oral obesity treatment in April. The FDA also issued warnings to telehealth firms marketing compounded weight-loss drugs.

LLY
MongoDB Shares Tumble on Weak Outlook, Analysts Cut Targets
Earnings

MongoDB Shares Tumble on Weak Outlook, Analysts Cut Targets

MongoDB shares fell sharply following a quarterly report that beat earnings but offered a weaker-than-expected forecast, prompting several analyst target cuts.

MDB SNOW OKTA QQQ SPY
CrowdStrike Stock Gains on Strong Q4 Results and Upbeat Long-Term Targets
Earnings

CrowdStrike Stock Gains on Strong Q4 Results and Upbeat Long-Term Targets

CrowdStrike reported better-than-expected fourth-quarter results, with annual recurring revenue exceeding $5 billion. The company provided a robust long-term forecast through fiscal 2027, sending shares higher in extended trading.

CRWD MSFT PANW S XLK
Broadcom Shares Dip Ahead of Q1 Report Amid RBC Target Cut, AI Demand Scrutiny
Earnings

Broadcom Shares Dip Ahead of Q1 Report Amid RBC Target Cut, AI Demand Scrutiny

Broadcom shares declined 1.6% to $313.84 Tuesday, with RBC Capital reducing its price target to $340 from $370 ahead of the chipmaker's quarterly results. The market is focused on AI infrastructure spending durability and VMware software growth.

AVGO XLK
Adobe Shares Surge Ahead of Q1 Earnings, AI Monetization in Focus
Earnings

Adobe Shares Surge Ahead of Q1 Earnings, AI Monetization in Focus

Adobe shares gained 4.1% on Tuesday, defying broader market weakness, as investors look to the company's upcoming earnings report for clarity on AI monetization and acquisition progress.

ADBE
Credo Technology Shares Plunge on Margin Guidance Despite Record Sales
Earnings

Credo Technology Shares Plunge on Margin Guidance Despite Record Sales

Credo Technology shares dropped sharply after the company projected a decline in gross margins for the current quarter, overshadowing record fiscal Q3 revenue and an acquisition.

CRDO
MongoDB Plunges on Soft Guidance and Sales Leadership Overhaul
Earnings

MongoDB Plunges on Soft Guidance and Sales Leadership Overhaul

MongoDB shares tumbled over 21% following a cautious first-quarter outlook and management shifts in its sales organization. Analyst firm Baird downgraded the stock, citing concerns over Atlas growth.

MDB
ImmunityBio Shares Dip Ahead of Key Business Update Call
Earnings

ImmunityBio Shares Dip Ahead of Key Business Update Call

ImmunityBio shares edged lower in premarket activity Tuesday, giving back some of the prior session's gains ahead of a scheduled business update and full-year results call later in the day.

IBRX MRK